• 1
    Ravetch, J. V. and Lanier, L. L., Immune inhibitory receptors. Science 2000. 290: 8489.
  • 2
    Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A. and Sharpe, A. H., Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995. 3: 541547.
  • 3
    Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H. and Mak, T. W., Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995. 270: 985988.
  • 4
    Siegel, R. M. and Fleisher, T. A., The role of Fas and related death receptors in autoimmune and other disease states. J. Allergy Clin. Immunol. 1999. 103: 729738.
  • 5
    Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T. and Nagata, S., Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994. 76: 969976.
  • 6
    Nishimura, H., Nose, M., Hiai, H., Minato, N. and Honjo, T., Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999. 11: 141151.
  • 7
    Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N. and Honjo, T., Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001. 291: 319322.
  • 8
    Nishimura, H. and Honjo, T., PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol. 2001. 22: 265268.
  • 9
    Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y., Long, A. J., Brown, J. A., Nunes, R., Greenfield, E. A., Bourque, K., Boussiotis, V. A., Carter, L. L., Carreno, B. M., Malenkovich, N., Nishimura, H., Okazaki, T., Honjo, T., Sharpe, A. H. and Freeman, G. J., PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2001. 2: 261268.
  • 10
    Agata, Y., Kawasaki, A., Nishimura, H., Ishida, Y., Tsubata,T., Yagita, H. and Honjo, T., Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int. Immunol. 1996. 8: 765772.
  • 11
    Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., Horton, H. F., Fouser, L., Carter, L., Ling, V., Bowman, M. R., Carreno, B. M., Collins, M., Wood, C. R. and Honjo, T., Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 2000. 192: 10271034.
  • 12
    Chambers, C. A., Kuhns, M. S. and Allison, J. P., Cytotoxic T lymphocyte antigen-4(CTLA-4) regulates primary and secondary peptide-specific CD4(+) T cell responses. Proc. Natl. Acad. Sci. USA 1999. 96: 8603868.
  • 13
    Chambers, C. A., Sullivan, T. J., Truong, T. and Allison, J. P., Secondary but not primary T cell responses are enhanced in CTLA-4-deficient CD8+ T cells. Eur. J. Immunol. 1998. 28: 31373143.
  • 14
    Bachmann, M. F., Waterhouse, P., Speiser, D. E., McKall-Faienza, K., Mak, T. W. and Ohashi, P. S., Normal responsiveness of CTLA-4-deficient anti-viral cytotoxic T cells. J. Immunol. 1998. 160: 95100.
  • 15
    Whitmire, J. K., Slifka, M. K., Grewal, I. S., Flavell, R. A. and Ahmed, R., CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection. J. Virol. 1996. 70: 83758381.
  • 16
    Coles, M. C., McMahon, C. W., Takizawa, H. and Raulet, D. H., Memory CD8 T lymphocytes express inhibitory MHC-specific Ly49 receptors. Eur. J. Immunol. 2000. 30: 236244.
  • 17
    Jenkins, M. K., Taylor, P. S., Norton, S. D. and Urdahl, K. B., CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J. Immunol. 1991. 147: 24612466.
  • 18
    Shuford, W. W., Klussman, K., Tritchler, D. D., Loo, D. T., Chalupny, J., Siadak, A. W., Brown, T. J., Emswiler, J., Raecho, H., Larsen, C. P., Pearson, T. C., Ledbetter, J. A., Aruffo, A. and Mittler, R. S., 4–1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J. Exp. Med. 1997. 186: 4755.
  • 19
    Dong, H., Zhu, G., Tamada, K. and Chen, L., B7-H1, a third member of the B7 family, co-stimulates T cell proliferation and interleukin-10 secretion. Nat. Med. 1999. 5: 13651369.
  • 20
    Tamura, H., Dong, H., Zhu, G., Sica, G. L., Flies, D.B., Tamada, K. and Chen, L., B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. Blood 2001. 97: 18091816.
  • 21
    Tseng, S. Y., Otsuji, M., Gorski, K., Huang, X., Slansky, J. E., Pai, S. I., Shalabi, A., Shin, T., Pardoll, D. M. and Tsuchiya, H., B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J. Exp. Med. 2001. 193: 839846.
  • 22
    Krummel, M. F. and Allison, J. P., CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 1995. 182: 459465.
  • 23
    Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B. and Bluestone, J. A., CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994. 1: 405413.
  • 24
    Krummel, M. F. and Allison, J. P., CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 1996. 183: 25332540.
  • 25
    Brunner, M. C., Chambers, C. A., Chan, F. K., Hanke, J., Winoto, A. and Allison, J. P., CTLA-4-mediated inhibition of early events of T cell proliferation. J. Immunol. 1999. 162: 58135820.
  • 26
    Chambers, C. A., Sullivan, T. J. and Allison, J. P., Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells. Immunity 1997. 7: 885895.
  • 27
    Bachmann, M. F., Gallimore, A., Jones, E., Ecabert, B., Acha-Orbea, H. and Kopf, M., Normal pathogen-specific immune responses mounted by CTLA-4-deficient T cells: a paradigm reconsidered. Eur. J. Immunol. 2001. 31: 450458.
  • 28
    Ugolini, S., Arpin, C., Anfossi, N., Walzer, T., Cambiaggi, A., Forster, R., Lipp, M., Toes, R. E., Melief, C. J., Marvel, J. and Vivier, E., Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells. Nat. Immunol. 2001. 2: 430435.
  • 29
    Peacock, C. D., Lin, M. Y., Ortaldo, J. R. and Welsh, R. M., The virus-specific and allospecific cytotoxic T-lymphocyte response to lymphocytic choriomeningitis virus is modified in a subpopulation of CD8(+) T cells coexpressing the inhibitory major histocompatibility complex class I receptor Ly49G2. J. Virol. 2000. 74: 70327038.
  • 30
    Hayashi, R. J., Loh, D. Y., Kanagawa, O. and Wang, F., Differences between responses of naive and activated T cells to anergy induction. J. Immunol. 1998. 160: 3338.
  • 31
    Dubois, P. M., Pihlgren, M., Tomkowiak, M., Van Mechelen, M. and Marvel, J., Tolerant CD8 T cells induced by multiple injections of peptide antigen show impaired TCR signaling and altered proliferative responses in vitro and in vivo. J. Immunol. 1998. 161: 52605267.
  • 32
    Schwartz, R. H., T cell clonal anergy. Curr. Opin. Immunol. 1997. 9: 351357.
  • 33
    Beverly, B., Kang, S. M., Lenardo, M. J. and Schwartz, R. H., Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int. Immunol. 1992. 4: 661671.
  • 34
    Maier, C. C. and Greene, M. I., Biochemical features of anergic T cells. Immunol. Res. 1998. 17: 133140.
  • 35
    Boussiotis, V. A., Freeman, G. J., Taylor, P. A., Berezovskaya, A., Grass, I., Blazar, B. R. and Nadler, L. M., p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes. Nat. Med. 2000. 6: 290297.
  • 36
    Kaye, J., Hsu, M. L., Sauron, M. E., Jameson, S. C., Gascoigne, N. R. and Hedrick, S. M., Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor. Nature 1989. 341: 746749.
  • 37
    Sha, W. C., Nelson, C. A., Newberry, R. D., Kranz, D. M., Russell, J. H. and Loh, D. Y., Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice. Nature 1988. 335: 271274.
  • 38
    Blair, P. J., Riley, J. L., Levine, B. L., Lee, K. P., Craighead, N., Francomano, T., Perfetto, S. J., Gray, G. S., Carreno, B. M. and June, C. H., CTLA-4 ligation delivers a unique signal to resting human CD4 T cells that inhibits interleukin-2 secretion but allows Bcl-X(L) induction. J. Immunol. 1998. 160: 1215.
  • 39
    Ranganath, S., Ouyang, W., Bhattarcharya, D., Sha, W. C., Grupe, A., Peltz, G. and Murphy, K. M., GATA-3-dependent enhancer activity in IL-4 gene regulation. J. Immunol. 1998. 161: 38223826.
  • 40
    Ory, D. S., Neugeboren, B. A. and Mulligan, R. C., A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. USA 1996. 93: 1140011406.
  • 41
    Cook, J. R., Wormstall, E. M., Hornell, T., Russell, J., Connolly, J. M. and Hansen, T. H., Quantitation of the cell surface level of Ld resulting in positive versus negative selection of the 2C transgenic T cell receptor in vivo. Immunity 1997. 7: 233241.